TY - JOUR
T1 - A systematic review of cost-effectiveness studies of prevention and treatment for eating disorders
AU - Le, Long Khanh Dao
AU - Hay, Phillipa
AU - Mihalopoulos, Cathrine
N1 - Funding Information:
The study was funded by a National Health and Medical Research Council (NHMRC) Centre for Research Excellence Grant (APP1041131). The views expressed in this study are solely those of the authors and do not reflect the views of the NHMRC. L.K.-D.L. is a recipient of CREMSI (APP1041131) and Deakin University Post-Graduate Scholarship. During the conduct of this work, CM was funded by a NHMRC Early Career Fellowship Grant (APP1035887).
Funding Information:
The authors acknowledge Miss Jenifer David for proof reading of the manuscript. The study was funded by a National Health and Medical Research Council (NHMRC) Centre for Research Excellence Grant (APP1041131). The views expressed in this study are solely those of the authors and do not reflect the views of the NHMRC. L.K.-D.L. is a recipient of CREMSI (APP1041131) and Deakin University Post-Graduate Scholarship. During the conduct of this work, CM was funded by a NHMRC Early Career Fellowship Grant (APP1035887).
Publisher Copyright:
© 2017, © The Royal Australian and New Zealand College of Psychiatrists 2017.
PY - 2018/4
Y1 - 2018/4
N2 - Background: Eating disorders are serious mental disorders and are associated with substantial economic and social burden. The aim of this study is to undertake a systematic review of the cost-effectiveness studies of both preventive and treatment interventions for eating disorder. Method: Electronic databases (including the Cochrane Controlled Trial Register, MEDLINE, PsycINFO, Academic Search Complete, Global Health, CINAHL complete, Health Business Elite, Econlit, Health Policy Reference Center and ERIC) were searched for published cost-effectiveness studies of eating disorder prevention and treatment including papers published up to January 2017. The quality of studies was assessed using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist. Results: In all, 13 studies met the review inclusion criteria as full cost-effectiveness studies and 8 were published since 2011. The studies included three modelled and one trial-based study focused on prevention, two trial-based and one modelled study for anorexia nervosa treatment and three trial-based studies for bulimia nervosa treatment. The remaining studies targeted binge-eating disorder or non-specific eating disorder treatment. The average percent of CHEERS checklist items reported was 71% (standard deviation 21%). Eating disorder interventions were mainly cost-saving or more effective and more costly compared to comparators; however, some results did not reach statistical significance. In the two studies that achieved 100% CHEERS checklist, one study reported that a cognitive dissonance intervention might be cost-effective for prevention of anorexia nervosa and bulimia nervosa with a 90% participation rate and the second study supported lisdexamfetamine to be cost-effective in the treatment of binge-eating disorder. Insufficient evidence for long-term cost-effectiveness (e.g. over 2 years) was found. Conclusion: Cost-effectiveness studies in eating disorder appear to be increasing in number over the last 6 years. Findings were inconsistent and no firm conclusion can be drawn with regard to comparative value-for-money conclusions. However, some promising interventions were identified. Further research with improved methodology is required.
AB - Background: Eating disorders are serious mental disorders and are associated with substantial economic and social burden. The aim of this study is to undertake a systematic review of the cost-effectiveness studies of both preventive and treatment interventions for eating disorder. Method: Electronic databases (including the Cochrane Controlled Trial Register, MEDLINE, PsycINFO, Academic Search Complete, Global Health, CINAHL complete, Health Business Elite, Econlit, Health Policy Reference Center and ERIC) were searched for published cost-effectiveness studies of eating disorder prevention and treatment including papers published up to January 2017. The quality of studies was assessed using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist. Results: In all, 13 studies met the review inclusion criteria as full cost-effectiveness studies and 8 were published since 2011. The studies included three modelled and one trial-based study focused on prevention, two trial-based and one modelled study for anorexia nervosa treatment and three trial-based studies for bulimia nervosa treatment. The remaining studies targeted binge-eating disorder or non-specific eating disorder treatment. The average percent of CHEERS checklist items reported was 71% (standard deviation 21%). Eating disorder interventions were mainly cost-saving or more effective and more costly compared to comparators; however, some results did not reach statistical significance. In the two studies that achieved 100% CHEERS checklist, one study reported that a cognitive dissonance intervention might be cost-effective for prevention of anorexia nervosa and bulimia nervosa with a 90% participation rate and the second study supported lisdexamfetamine to be cost-effective in the treatment of binge-eating disorder. Insufficient evidence for long-term cost-effectiveness (e.g. over 2 years) was found. Conclusion: Cost-effectiveness studies in eating disorder appear to be increasing in number over the last 6 years. Findings were inconsistent and no firm conclusion can be drawn with regard to comparative value-for-money conclusions. However, some promising interventions were identified. Further research with improved methodology is required.
KW - Cost-effectiveness study
KW - eating disorders
KW - prevention
KW - systematic review
KW - treatment
UR - http://www.scopus.com/inward/record.url?scp=85043367942&partnerID=8YFLogxK
U2 - 10.1177/0004867417739690
DO - 10.1177/0004867417739690
M3 - Review Article
C2 - 29113456
AN - SCOPUS:85043367942
SN - 0004-8674
VL - 52
SP - 328
EP - 338
JO - Australian and New Zealand Journal of Psychiatry
JF - Australian and New Zealand Journal of Psychiatry
IS - 4
ER -